- Home
- AMLX vs UVE Comparison
AMLX vs UVE Comparison
Compare AMLX & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMLX
- UVE
- Stock Information
- Founded
- AMLX 2014
- UVE 1990
- Country
- AMLX United States
- UVE United States
- Employees
- AMLX N/A
- UVE N/A
- Industry
- AMLX Biotechnology: Pharmaceutical Preparations
- UVE Property-Casualty Insurers
- Sector
- AMLX Health Care
- UVE Finance
- Exchange
- AMLX Nasdaq
- UVE Nasdaq
- Market Cap
- AMLX 481.9M
- UVE 565.2M
- IPO Year
- AMLX 2022
- UVE 1992
- Fundamental
- Price
- AMLX $3.45
- UVE $19.54
- Analyst Decision
- AMLX Buy
- UVE Buy
- Analyst Count
- AMLX 7
- UVE 1
- Target Price
- AMLX $7.60
- UVE $25.00
- AVG Volume (30 Days)
- AMLX 921.2K
- UVE 139.8K
- Earning Date
- AMLX 02-20-2025
- UVE 02-20-2025
- Dividend Yield
- AMLX N/A
- UVE 3.27%
- EPS Growth
- AMLX N/A
- UVE 4.62
- EPS
- AMLX N/A
- UVE 2.48
- Revenue
- AMLX $196,485,000.00
- UVE $1,511,183,000.00
- Revenue This Year
- AMLX N/A
- UVE N/A
- Revenue Next Year
- AMLX N/A
- UVE N/A
- P/E Ratio
- AMLX N/A
- UVE $7.87
- Revenue Growth
- AMLX N/A
- UVE 12.23
- 52 Week Low
- AMLX $1.58
- UVE $15.78
- 52 Week High
- AMLX $19.95
- UVE $23.39
- Technical
- Relative Strength Index (RSI)
- AMLX 38.58
- UVE 38.75
- Support Level
- AMLX $3.02
- UVE $19.29
- Resistance Level
- AMLX $3.67
- UVE $19.80
- Average True Range (ATR)
- AMLX 0.26
- UVE 0.52
- MACD
- AMLX 0.01
- UVE -0.01
- Stochastic Oscillator
- AMLX 37.07
- UVE 32.67
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.
About UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.